Recent Blog Posts
View Post: Metronomic chemotherapy with daily, oral etoposide plus ...
19 Nov 2009 by H S Friedman
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605412 ...
View Blog: British Journal of Cancer - AOP - nature.com... - http://feeds.nature.com/bjc/rss/aop
View Post: ANTI-CANCER
2 Dec 2009
Slide 44: B. ETOPOSIDE & TENIPOSIDE • Podophyllotoxins from May apple root • interacts w/ topoisomerase II….>inhibits mitochondrial electron transport….> increase degradation of DNA • late S and early G2 phase • oral; elimination thru ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/
View Post: Research of Cancer Risk
Tobacco Facts.
2 Dec 2009 by admin ...
View Blog: http://www.tobacco-facts.net/
View Post: Lymphoma Clinical Trial: Combination Chemotherapy and Radiation ...
2 Dec 2009
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing... ... bleomycin sulfate IV over at least 10 minutes or subcutaneously (SC) and vincristine sulfate IV on days 1 and 8; etoposide IV over 1-2 hours on days 1-3; oral prednisone twice daily on days 1-7; and filgrastim* SC or IV daily beginning on day 4 and continuing until blood counts recover. ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...
View Post: Biofunctionalized magnetic-vortex microdiscs for targeted cancer ...
3 Dec 2009
The release of cytochrome c upon translocation of Bax has been attributed to induction of the mitochondrial ... define a sequence of biochemical events that mediates the apoptosis induced by etoposide. This cascade proceeds by coupling . .... of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer Additive or supraadditive activity of ... protracted manner, endothelial cells are preferentially affected via inhibition of proliferation and induction of apoptosis. ...
View Blog: Recent Ion Channel Publications compiled... - http://www.ionchannels.org/
View Post: Advances in Molecular Drug Development Highlighted
16 Nov 2009 by AACR Communications Staff
Researchers have already evaluated the use of the oral poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor olaparib and its antitumor activity pre-clinically and in patients with breast and ovarian cancer that contain ...
View Blog: AACR News - http://aacrnews.wordpress.com/
View Post: Can BCL-2 inhibitors make progress in SCLC?
14 Oct 2009 by Dr Sanborn
It is administered intravenously (as opposed to the AT-101, which is an oral therapy), and has been studied in combination with topotecan in early phase trials. In a phase I trial presented at ASCO this year, obatoclax was combined with ...
View Blog: GRACE :: Lung Cancer - http://cancergrace.org/lung/
View Post: Republic of Angola (Xyami): Brain Tumor News Blast!
22 Nov 2009 by Francis*PAC
http://virtualtrials.com/news3.cfm?item=4691 :European advisory committee declines to recommend Avastin approval for deadly brain cancer. ===================================================================== http://virtualtrials.com/news3. cfm?item=4692 :Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. ===================================================================== ...
View Blog: Republic of Angola (Xyami) - http://republica-de-angola.blogspot.com/
View Post: Nationwide Registry to “Match” Study Volunteers With Researchers ...
11 Nov 2009 by Paul Cacciatore
Oral etoposide for refractory or recurrent epithelial ovarian cancer. J Med Assoc Thai. 2009 Nov;92(11):1397-405 Authors: Thavaramara T, Tangjitgamol S, Manusirivithaya S, Leelahakorn S OBJECTIVE: To study the response rate (RR), ...
View Blog: Libby's H*O*P*E* (*Helping *Ovarian Cancer... - http://healthinfoispower.wordpress.com/

Not Signed In -

